InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Jones Paul A., Directeur du Développement du Leadership. Officer active across 1 company, notably Usana Health Sciences INC. In total, 17 disclosures have been published. Split: 0 buy · 5 sells. Total volume traded: €1.1m. Activity tracked since 3 November 2021. The latest transaction was disclosed on 13 August 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Jones Paul A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
4,596 sharesCommon StockSEC:0001565541-26-000006:0
2,174 sharesCommon StockSEC:0001565541-26-000002:0
1,456 sharesCommon StockSEC:0000896264-25-000044:0
2,174 sharesCommon StockSEC:0000896264-25-000026:0
6,266 shares@ US$38.379617.1% of flowCommon StockSEC:0000896264-24-000212:0
2,714 shares@ US$48.66019.5% of flowCommon StockSEC:0000896264-24-000174:0
1,457 sharesCommon StockSEC:0000896264-24-000069:0
2,174 sharesCommon StockSEC:0000896264-24-000049:0
956 sharesCommon StockSEC:0000896264-24-000029:0
3,682 shares@ US$65.0017.0% of flowCommon StockSEC:0001415889-23-011582:0
1,373 sharesCommon StockSEC:0001415889-23-002184:0
955 sharesCommon StockSEC:0001415889-23-002055:0
5,029 shares@ US$70.0027.1% of flowCommon StockSEC:0001415889-22-008741:0
1,457 sharesCommon StockSEC:0001179110-22-000984:0
956 sharesCommon StockSEC:0001179110-22-000933:0
2,136 shares@ US$101.248817.1% of flowCommon StockSEC:0001179110-21-009893:0
549 sharesCommon StockSEC:0001179110-21-009647:0
17 of 17 declarations
About Jones Paul A.
Jones Paul A. is Director of Leadership Development and a declarant linked to Usana Health Sciences INC, where he also holds the role of CHIEF PEOPLE OFFICER. He has 17 filings in total, and across the sampled recent filings from 2021-10-26 to 2026-03-03, sales total EUR 1091861, with the modal transaction nature listed as option exercise.
